The relationship between heart rate variability and glucose clearance in healthy men and women.

Heart rate variability (HRV) is a non-invasive indicator of the activity of the autonomic nervous system, which regulates many physiological functions including metabolism. The purpose of this study was to quantify the relationship between resting markers of HRV and oral glucose tolerance test (OGTT) response. Eighteen healthy individuals (10 males, 8 females, (23.8±2.9 years) underwent a 10-minute resting HRV recording. The final five minutes were evaluated via Kubios HRV Standard for: root mean square of successive differences (RMSSD), standard deviation of normal-to-normal sinus beats (SDNN), high frequency (HF), and low frequency (LF). A standard 2-hour OGTT was then administered. Glucose was measured via finger stick before, 30-minutes post, 1-hour post, and 2-hours post OGTT. Pearson correlations demonstrated that RMSSD, SDNN, HF and LF were strongly correlated to fasting blood glucose (FBG) for the group (p<0.05) but not for glucose area under the curve (AUC). When analyzed by sex, only males demonstrated significant correlations between AUC and RMSSD, SDNN, and LF (p<0.05). An independent samples t-test revealed no sex differences for FBG, AUC, RMSSD, SDNN, HF and LF. These findings provide new and interesting insights into the relationship of autonomic activity and glucose uptake, highlighting sex-based relationships.

Autonomic Rebound Following Maximal Exercise in Bodybuilders and Recreationally Active Participants.

The off-season for natural bodybuilders (BB) is characterized by increased training loads and fluctuations in caloric intake, which may lead to insufficient recovery. The autonomic nervous system (ANS) plays a pivotal role in recovery. The purpose of this study was to evaluate resting ANS activity and recovery following a maximal exercise bout in off-season BB and compare them to those of recreationally active individuals. Fifteen males participated; 7 recreationally active (RA) (24.6 ± 2.1 years, 81.1 ± 10.8 kg) and 8 BB (21.8 ± 2.9 years, 89.3 ± 13.0 kg). Each performed a graded exercise test. Heart rate variability (HRV) was measured at rest and during a 45 min recovery period. HRV was analyzed as: root mean square of successive differences (lnRMSSD), standard deviation of normal-to-normal sinus beats (lnSDNN), high frequency (lnHF), low frequency (lnLF), and the ratio of low frequency to high frequency (lnLF/lnHF). A one-way ANOVA showed no differences for any resting marker of HRV, HR, and HR recovery. A significant depression in all markers of HRV was observed in the BB group at the 15 min point, and no recovery was observed before 45 min when compared to RA. The results of this study demonstrated depressed HRV recovery following the graded exercise test in BB when compared to the RA group.

A Comparison of Anaerobic Power Tests using Cycle Ergometry and Nonmotorized Treadmill Ergometry at Optimized Loads.

The purpose of this study was to compare performance markers derived from a 30-second maximal bout on a cycle ergometer (CE) and non-motorized treadmill (NMT) under optimized loads. Recreationally active participants (n = 40) volunteered for the study. Force-velocity tests on the CE and NMT were used to determine optimal resistance for peak power (PP) production. The remaining visits were randomized and counterbalanced, with a single 30-second maximal test on CE or NMT to assess PP, mean power (MP), fatigue index (FI), over the course of the 30-second test, and maximum heart rate (HRmax) and blood lactate (BLa-) taken 1-minute post. Results were that PP and MP were higher (P<0.05) on CE compared to NMT for both sexes. FI did not differ among males (P=0.201) whereas females showed higher FI (P=0.002) on the CE. HRmax and BLa- were higher (P<0.05) after NMT for both sexes. There was no difference for optimal braking force on NMT between males (16.65±4.49%BW) and females (14.30±3.10%BW) (P=0.061). CE optimal torque factor was higher for males (0.78±0.16 Nm/kg) compared to females (0.62±0.14 Nm/kg) (P=0.001). Overall, CE produced higher power output using optimized loads in recreationally active males and females, while NMT test resulted in a higher HRmax and BLa- concentration. These tests for anaerobic power, when performed with optimized loads, produced different results for several variables, therefore these modalities should not be considered interchangeable. Practitioners should consider which modality best mimics the activities of the person being tested when selecting a protocol.

Carbohydrate Rinse Fails to Enhance Cycling Performance or Alter Metabolic and Autonomic Recovery in Recreational Cyclists.

The purpose of the study was to examine the effects of carbohydrate (CHO) mouth rinsing on autonomic and metabolic recovery as well as cycling performance. Ten male recreational cyclists (age = 30 ± 6 years, VO2peak = 54.5 ± 8.1 mL·kg-1·min-1) completed a randomized, double-blind, placebo-controlled, crossover designed study. A CHO or a placebo (PLA) rinse was administered every 12.5% of a work to completion trial (75%Wmax). Heart rate variability (lnRMSSD), the respiratory exchange ratio, and plasma epinephrine, norepinephrine, insulin, glucose, free fatty acids (FFA), and lactate were measured pre- and post-exercise. The CHO rinse did not improve time to completion of the test trial (CHO: 4108 ± 307 s, PLA: 4176 ± 374 s, p = 0.545). Further, the CHO rinse did not impact autonomic recovery, as measured by lnRMSSD (p = 0.787) and epinephrine (p = 0.132). Metabolic biomarkers were also unaffected by the CHO rinse, with no differences observed in responses of FFA (p = 0.064), lactate (p = 0.302), glucose (p = 0.113) or insulin (p = 0.408). Therefore, the CHO mouth rinse does not reduce the acute sympathetic response following strenuous exercise and does not result in improvements in cycling time to completion.

The Effects of Caffeine and Citrus Aurantium on Performance During Repeated Maximal Anaerobic Exercise Bouts in Habitual Caffeine Users.

ABSTRACT: McLester, CN, Bailey, P, Bechke, EE, Williamson, CM, McLester, JR, and Kliszczewicz, B. The effects of caffeine and Citrus aurantium on performance during repeated maximal anaerobic exercise bouts in habitual caffeine users. J Strength Cond Res 35(12): 3394-3399, 2021-The combination of caffeine (CAF) and Citrus aurantium (CA) have demonstrated the potential to improve various types of performance. To date, few studies have explored this relationship in purely anaerobic-based exercise. Therefore, the purpose of this study was to examine the influence of an acute dose of CAF + CA on peak anaerobic performance and the attenuation of power over multiple anaerobic bouts and to determine any differences in perceived effort or fatigue. Ten active men (25.1 ± 3.9 years) who habitually consumed caffeine volunteered to perform repeated anaerobic bouts on a cycle ergometer on 2 separate days, consuming either a placebo or 100 mg CAF + 100 mg CA. Significance was set at p ≤ 0.05 and repeated measures analysis of variance showed no main effects for peak power p = 0.520, mean power p = 0.926, minimum power p = 0.321, total work p = 0.924, time to peak power p = 0.536, or rate of fatigue p = 0.284. There was a time effect for all variables (p ≤ 0.05) with the exception of time to peak power (p = 0.181). There were no differences in any measures of perceived effort or fatigue between conditions (p ≥ 0.05), but there were time-dependent differences observed each day (p ≤ 0.05). Overall, an acute dosage of 100 mg CAF and 100 mg CA did not elicit any differences in anaerobic performance or in perceived measures of effort and fatigue in young males who habitually consume caffeine. Therefore, caution should be used when pairing CAF and CA for the goal of improving anaerobic performance, because no clear benefit was realized in this population at this dosage.

An examination of single day vs. multi-day heart rate variability and its relationship to heart rate recovery following maximal aerobic exercise in females.

The purpose of this study was to examine the relationship of a single day measure of heart rate variability (HRV), and the averaged baseline measures of HRV to heart rate recovery (HRR) following maximal exercise. Thirty females (22.9 ± 3.2 years, 64.8 ± 8.4 kg) completed four visits (V1-V4), where a 10-min HRV was recorded. Upon completing the V4 recording, a treadmill graded exercise test (GXT) was performed, followed by a 5-min active cool down. HRV was assessed through time domain measures [natural log of root mean square of successive R-R differences (lnRMSSD) and standard deviation of normal to normal intervals (lnSDNN)] and natural log frequency domain measures [low frequency (lnLF) and high frequency (lnHF)]. Variables collected over V1-V4 were measured as; day of (DO) GXT, 3 day (AV3), and 4 day average (AV4). HRR was calculated as the maximal HR achieved minus the HR at: 30-s (HRR30), 1-min (HRR1), 2-min (HRR2), 3-min (HRR3), 4-min (HRR4) or 5-min (HRR5) of recovery. Pearson's Product correlations revealed significant correlations (P = < 0.05) between all HRVDO measures to each HRR measure and are presented in ranges: lnSDNN (r = 0.442-0.522), lnRMSSD (r = 0.458-0.514), lnLF (r = 0.368-0.469), lnHF (r = 0.422-0.493). For HRVAV3, lnRMSSDAV3 and HRR1 were positively correlated (r = 0.390, P = 0.033). Last, HRVAV4 showed positive relationships (P = < 0.05) between lnRMSSDAV4 and HRR30 (r = 0.365, P = 0.048); and for HRR1 and lnSDNNAV4 (r = 0.400, P = 0.029), lnRMSSDAV4 (r = 0.442, P = 0.014), and lnHFAV4 (r = 0.368, P = 0.045); and lnRMSSDAV4 and HRR3 (r = 0.381, P = 0.038). Within the current study HRVDO displayed the strongest correlations to HRR therefore, averaged resting HRV measures do not strengthen the prediction of cardiovascular recovery following a GXT in this population.

Development of a dual-energy X-ray absorptiometry-derived body volume equation in Hispanic adults for administering a four-compartment model.

The purpose of the present study was: (1) to develop a new dual-energy X-ray absorptiometry (DXA)-derived body volume (BV) equation with the GE-Lunar prodigy while utilising underwater weighing (UWW) as a criterion and (2) to cross-validate the novel DXA-derived BV equation (4C-DXANickerson), Wilson DXA-derived BV equation (4C-DXAWilson) and air displacement plethysmography (ADP)-derived BV (4C-ADP) in Hispanic adults. A total of 191 Hispanic adults (18-45 years) participated in the present study. The development sample consisted of 120 females and males (50 % females), whereas the cross-validation sample comprised of forty-one females and thirty males (n 71). Criterion body fat percentage (BF %) and fat-free mass (FFM) were determined using a four-compartment (4C) model with UWW as a criterion for BV (4C-UWW). 4C-DXANickerson, 4C-DXAWilson and 4C-ADP were compared against 4C-UWW in the cross-validation sample. 4C-DXANickerson, 4C-DXAWilson and 4C-ADP all produced similar validity statistics when compared with 4C-UWW in Hispanic males (all P > 0·05). 4C-DXANickerson also yielded similar BF % and FFM values as 4C-UWW when evaluating the mean differences (constant error (CE)) in Hispanic females (CE = -0·79 % and 0·38 kg; P = 0·060 and 0·174, respectively). However, 4C-DXAWilson produced significantly different BF % and FFM values (CE = 3·22 % and -2·20 kg, respectively; both P < 0·001). Additionally, 4C-DXAWilson yielded significant proportional bias when estimating BF % (P < 0·001), whereas 4C-ADP produced significant proportional bias for BF % and FFM (both P < 0·05) when evaluated in Hispanic females. The present study findings demonstrate that 4C-DXANickerson is a valid measure of BV in Hispanics and is recommended for use in clinics, where DXA is the main body composition assessment technique.

Relative accuracy of anthropometric-based body fat equations in males and females with varying BMI classifications.

BACKGROUND: BMI based body fat equations developed from Womersley and Durnin (BMIWO), Jackson et al. (BMIJA), Deurenberg et al. (BMIDE), and Gallagher et al. (BMIGA) are commonly used to quantify body fat percentage (BF%). However, relative fat mass (RFM) is a new anthropometric-based method that has been proposed as an alternative. AIMS: The purpose of this study was to examine the independent and interactive effects of sex and BMI classification on the relative accuracy of BMI-based body fat equations and RFM. METHODS: Males (n = 75) and females (n = 75) were stratified and classified into three different groups; 1) normal weight (n = 50 [NW: 50% males]; BMI<25.0 kg/m2); 2) overweight (n = 50 [OW: 50% males]; BMI≥25.0-29.9 kg/m2); 3) obese (n = 50 [OB: 50% males]; BMI≥30.0 kg/m2). A criterion three-compartment model (3C model) was determined with air displacement plethysmography for body volume and multi-frequency bioimpedance analysis for total body water. Data were stratified by sex and BMI classification. Difference scores were created by subtracting estimated BF% from 3C model BF%. RESULTS: A significant SEX × BMI interaction was detected for all comparisons (all p < 0.05). Post hoc analysis indicated the differences in BF% were statistically significant between OW females and males for all equations (BMIWO:-2.99 ± 4.79% vs. 4.71 ± 5.86%, p = 0.003; BMIJA:-1.77 ± 4.83% vs. 5.77 ± 5.85%, p < 0.001; BMIDE:-3.09 ± 4.80% vs. 4.97 ± 5.98%, p < 0.001; BMIGA:0.36 ± 4.51% vs. 4.56 ± 5.55%, p = 0.018; RFM:-2.17 ± 4.84% vs. 3.01 ± 5.34%, p = 0.004, respectively). In addition, there were significant differences between females and males classified as NW (BMIJA:-2.11 ± 4.15% vs. 2.61 ± 5.98%, p = 0.008) and OB (BMIGA:2.40 ± 3.36% vs. -1.09 ± 6.40%, p = 0.006). CONCLUSIONS: The current findings highlight that RFM does not appear to overcome error commonly associated with BMI-based body fat equations when stratifying by sex and BMI classification. Nonetheless, practitioners can use BMIWO, BMIDE, and RFM in males and females classified as NW or OB, but should employ caution prior to use in OW persons.

Agreement Between 2 Segmental Bioimpedance Devices, BOD POD, and DXA in Obese Adults.

This study examined the agreement between 2 segmental bioimpedance analysis (BIA) devices, air displacement plethysmography (BOD POD), and dual energy X-ray absorptiometry (DXA) for estimating body composition in obese adults. Fifty obese adults (25 men and 25 women; age = 34.20 ± 11.19 years; BMI = 36.14 ± 5.33 kg/m2) had their body fat percentage (BF%) and fat-free mass (FFM) evaluated with 2 segmental BIA devices (InBody 230 and InBody 720), BOD POD, and DXA (Lunar iDXA). Body composition via the BOD POD was determined using the Siri equation whereas manufacturer-based equations generated metrics (ie, BF% and FFM) for the InBody devices. The effect size of the mean differences for all BF% and FFM comparisons were trivial (Cohen's d < 0.20). The standard error of estimate (SEE), total error (TE), and 95% limits of agreement (LOAs) were low for both segmental BIA devices when compared to DXA (SEE < 2.26% and 2.35 kg; TE < 2.58% and 2.66 kg; 95% LOAs < ± 4.94% and 4.86kg). The error for BOD POD was also low when compared to DXA (SEE = 2.39% and 2.57 kg; TE = 2.34% and 2.56 kg; 95% LOAs = 4.63% and 5.06 kg). Validity statistics were slightly higher, but considered acceptable, when comparing the segmental BIA devices against BOD POD (SEE < 3.37% and 3.63 kg; TE < 3.44% and 3.79 kg; 95% LOAs < ± 6.62% and 7.19 kg). Lastly, the 2 segmental BIA devices produced nearly identical validity statistics when compared to each other. However, both BIA devices revealed proportional bias for BF% and FFM when compared to the BOD POD and DXA (all p < 0.05). The current study's findings indicate the InBody 230 is interchangeable with the InBody 720 in obese adults. Also, the trivial effect size, when compared against the BOD POD and DXA, suggest the InBody devices could be used for estimating group BF% and FFM. In contrast, the significant proportional bias demonstrates the BIA devices are not acceptable for individual estimates of body composition in an obese clinical population.

Effect of Low Back Pain Chronicity on Patient Outcomes Treated in Outpatient Physical Therapy: A Retrospective Observational Study.

OBJECTIVE: To examine the potential relationship between physical therapy (PT) treatment outcomes and chronicity of low back pain (LBP) in the outpatient setting. DESIGN: Retrospective observational study. SETTING: Outpatient PT clinics across 11 states. PARTICIPANTS: A total of 11,941 patients with LBP provided with PT services and discharged from care between January 1, 2017, and December 31, 2018. MAIN OUTCOME MEASURES: Focus on Therapeutic Outcome Low Back Functional Status (FS) Patient-Reported Outcome Measure (PROM) was the primary outcomes measure used. It assesses the patients' perceived physical abilities for patients experiencing LBP impairments. It determined a functional score on a linear metric ranging from 0 (low functioning) to 100 (high functioning). The difference in score between the intake FS and final FS score produced the FS change, which represented the overall improvement of the episode of care. RESULTS: The mean FS change was 16.997 (n=11,945). Patients with chronic symptoms (>90-d duration) had an FS change of 15.920 (n=7264) across 14.63 visits. Patients with subacute symptoms (15-90d) had an FS change of 21.66 (n=3631) across 14.05. Patients with acute symptoms (0-14d) had an FS change of 29.32 (n=1050) across 13.66 visits. Stepwise regression analysis revealed a significant â for chronicity (-4.155) with all models. CONCLUSIONS: Overall, this study shows patients experiencing shorter duration of LBP symptoms before starting a PT episode of care experience significantly better outcomes than patients who waited. Furthermore, the number of treatment session and duration of care was similar between groups, indicating potential ineffective or insufficient care was provided for patients with chronic pain.

Importance of Early Improvement in the Treatment of Low Back Pain With Physical Therapy.

STUDY DESIGN: .: A retrospective observational study. OBJECTIVE: Assess the time course of functional outcome improvements during a physical therapy (PT) episode of care for patients with low back pain. In addition, assess the impact of patient variables, such as symptom duration, on the time course of functional outcome improvements. SUMMARY OF BACKGROUND DATA: Early improvement in patient-reported symptoms and functional limitations may play an important role in the eventual success of an intervention. Early improvements in pain are associated with greater improvement in disability and depression in patients with low back pain. METHODS: A total 11,945 patients were included. Intake functional status (FS), FS change at discharge, predicted FS change at discharge, FS change at first progress report (FS1), duration of symptoms before treatment, and duration of PT episode of care were assessed. Pearson correlation analysis was used to assess correlation between collected variables and FS change. RESULTS: The mean FS change was 16.995 units, mean FS1 was 12.024 units, total duration was 63.591 days, and duration at FS1 was 28.969 days, indicating 70.72% of FS change occurred in the first 45.45% of the episode of care. Similar results occurred in all symptom duration categories, ranging from "0 to 7 days' to "greater than 6 months' duration. Correlation analysis demonstrated that FS1 had the greatest correlation to FS. A strong correlation (r > 0.7) was demonstrated in all symptom duration categories ranging from 0.741 to 0.805. CONCLUSION: The results of this study yield further support for the importance of rapid functional improvements during a PT episode of care. In addition, patients demonstrated roughly two-thirds of their improvement in the first 40% of visits regardless of their symptom duration. This study may help clinicians identify a need to modify a plan of care if insufficient early improvement is observed. LEVEL OF EVIDENCE: 3.

Reliability and Agreement of Various InBody Body Composition Analyzers as Compared to Dual-Energy X-Ray Absorptiometry in Healthy Men and Women.

BACKGROUND: Bioelectrical impedance analysis has evolved over the years to include the use of multiple frequencies and impedance measurements to improve the accuracy and reliability of body composition estimates. The purpose of this investigation was to evaluate the reliability of the InBody230, InBody720, and InBody770 to measure body fat percent (BF%), fat mass (FM), and fat-free mass (FFM) in the general population and to compare results to dual-energy X-ray absorptiometry (DXA). METHODS: A total of 31 males and 36 females participated in 2 d of testing separated by 24-72 h. Each visit consisted of a DXA scan, and analysis with the InBody230, InBody720, and InBody770. RESULTS: All 3 bioelectrical impedance devices (InBody230, InBody720, and InBody770) were reliable in men and women as indicated by high intraclass correlation coefficients for BF% (≥0.98), FM (≥0.98), and FFM (≥0.99) and low standard error of measurement for BF% (0.77%-0.99%), FM (0.54-0.87 kg), and FFM (0.58-0.84 kg) and minimum difference for BF% (2.12%-2.73%), FM (1.49-2.39 kg), and FFM (1.60-2.32 kg), respectively. When examining the agreement between the 3 InBody analyzers with DXA, systematic bias (underestimation of BF% and FM and overestimation of FFM) was present for all comparisons (p < 0.05) while proportional bias was present for FM in women and FFM in men. However, there was small individual error for all comparisons as indicated by the standard error of estimate and 95% limits of agreement. CONCLUSION: The InBody analyzers produce small individual error, which suggest these methods can be used as a surrogate when DXA is not available; however, practitioners should be aware of the systematic bias for all comparisons and proportional bias for FM in women and FFM in men. Furthermore, findings revealed that the research grade models, InBody720 and InBody770, added minimal benefit over the portable InBody230 when assessing BF%, FM, and FFM.

Citrus Aurantium and caffeine complex versus placebo on biomarkers of metabolism: a double blind crossover design.

BACKGROUOND: The purpose of this study was to examine resting the metabolic response to the ingestion of a complex containing Citrus Aurantium + Caffeine (CA + C) and if its consumption influences metabolic recovery following a high-intensity anaerobic exercise bout in habitual caffeine users. METHODS: Ten physically active males (25.1 ± 3.9 years; weight 78.71 ± 9.53 kg; height 177.2 ± 4.6 cm; body fat 15.5 ± 3.13%) participated in this study. This study was performed in a double-blind, randomized crossover fashion consisting of two exhaustive exercise protocols. On each visit the participants consumed either a CA + C (100 mg of CA and 100 mg of C) or placebo (dextrose) capsule. After consumption, participants were monitored throughout a 45-min ingestion period, then completed a repeated Wingate protocol, and were then monitored throughout a 45-min recovery period. Metabolic function was measured through blood glucose, plasma insulin, plasma triglycerides, and plasma catecholamines: epinephrine (E) and norepinephrine (NE). Biomarkers were taken at four different time points; Ingestion period: baseline (I1), post-ingestion period (I2); Recovery period: immediately post-exercise (R1), post-recovery period (R2). RESULTS: A repeated measures ANOVA revealed significant time-dependent increases in plasma E and NE at I2 only in the CA + C trial (p < 0.05), and a significant decrease in blood glucose at I2 in the PLA trial (p < 0.05); however, no meaningful changes in glucose was observed following CA + C ingestion. No changes in insulin or triglycerides were observed during the ingestion period. No trial-dependent differences were observed in the Recovery period. All biomarkers of metabolic recovery were equivalent when evaluating R1 v R2. Participants recovered in a similar time-dependent manner in all markers of metabolism following the PLA and CA + C trials. CONCLUSION: The findings of this study suggested that normal recommended dosages of 100 mg CA + 100 mg C is sufficient to promote glucose sparing at rest, with modest increases in SNS activity; however, the individual role of CA or C in this response cannot be determined.

Comparison of Muscle Activation Between Back Squats and Belt Squats.

Evans, TW, McLester, CN, Howard, JS, McLester, JR, and Calloway, JP. Comparison of muscle activation between back squats and belt squats. J Strength Cond Res 33(7S): S52-S59, 2019-A machine belt squat is a piece of equipment designed to allow the performance of squats while loading weight on the lifter's hips using a belt. The purpose of this investigation was to determine whether belt squats differ from back squats in activation of the primary movers and to determine the predictive capabilities of back squat load, training status, and anthropometric data on belt squat load. Thirty-one participants (16 men and 15 women) completed anthropometric measurements, a demographic questionnaire, a familiarization visit, and 2 testing visits, completing a 5 repetition maximum test for back squat and belt squat. Surface electromyography was used to measure muscle activation for the left and right vastus medialis, vastus lateralis, rectus femoris, and gluteus maximus (GM). Comparison of muscle activation between the 2 exercises showed significant differences in the left GM (back squat: 0.84 ± 0.45, belt squat: 0.69 ± 0.22, p = 0.015) and right GM (back squat: 0.86 ± 0.45, belt squat: 0.71 ± 0.29, p = 0.004). Regression analysis computed significant prediction equations for belt squat load for general population, men, women, and advanced lifters. Overall, results indicate that belt squats may significantly differ in GM activation from back squats. Back squat load, as well as other variables, may be effective in accurately estimating appropriate belt squat load. These findings may help to more appropriately program for training with machine belt squats as a back squat alternative.

Validity of DXA body volume equations in a four-compartment model for adults with varying body mass index and waist circumference classifications.

The purpose of this investigation was to determine the validity of 4-compartment (4C) model body fat percent (BF%) estimates when using dual energy x-ray absorptiometry (DXA) derived body volume (BV) equations (4C-DXA1 and 4C-DXA2) in adults with varying body mass index (BMI) and waist circumference (WC) classifications. Each model was compared to a criterion 4C model with air-displacement plethysmography (ADP) generated BV (4C-ADP). Participants were categorized as normal weight (n = 40; NW = BMI<25.0kg/m2); overweight (n = 40; OWBMI = BMI≥25.0 kg/m2); and overweight with at-risk WC (n = 35; OWBMI+WC = BMI≥25.0 kg/m2 and WC≥88.0cm for women and 102.0cm for men). 4C-DXA1 produced lower BF% than that derived using the 4C-ADP in NW (CE = -3.0%; p<0.001) while 4C-DXA2 was significantly higher (CE = 4.8%; p<0.001). The SEE and 95% limits of agreement (LOA) were lower for 4C-DXA2 (1.24% and ±2.5%, respectively) than 4C-DXA1 (2.59% and ±5.0%, respectively) and proportional bias was present for both (p<0.05). 4C-DXA1 BF% was not significant in OWBMI (CE = -0.5%; p = 0.112) whereas 4C-DXA2 was higher (CE = 4.5%; p<0.001). The SEE and 95% LOA were lower for 4C-DXA2 (1.20% and ±2.9%, respectively) than 4C-DXA1 (1.92% and ±3.9%, respectively) in OWBMI. Proportional bias was present for 4C-DXA1 (p = 0.007), but not 4C-DXA2 (p = 0.832). 4C-DXA1 and 4C-DXA2 produced significantly higher BF% in OWBMI+WC (CE = 2.2 and 2.3%, respectively; both p<0.001). The SEE and 95% LOA remained lower for 4C-DXA2 (1.15% and ±2.5%, respectively) than 4C-DXA1 (1.84% and ±3.8%, respectively). There was proportional bias for 4C-DXA2 (p = 0.020), but not 4C-DXA1 (p = 0.183) in OWBMI+WC. Only one prediction model (i.e., 4C-DXA1 in OWBMI+WC) revealed valid estimates of BF%. Practitioners are encouraged to use criteria for both BMI and WC when utilizing DXA-derived BV in 4C-models for normal and overweight populations.

An Investigation of the Differences between Perceived vs. Measured Body Composition, Social Physique Anxiety, and Overall Appearance Satisfaction among College Students.

The purpose of this study was to examine the differences between body composition, social physique anxiety (SPA) and appearance satisfaction among college students by sex and BMI. A secondary purpose was to assess levels of appearance satisfaction before and after body composition testing and discover any differences between perceived body fat percentage (BF%) and weight versus actual measurements. Participants included 212 college students (93 males, 119 females), 22.0 ± 2.2 years. They answered a demographic questionnaire, the Social Physique Anxiety Scale (SPAS), post-assessment questions, and underwent body composition testing via dual energy x-ray absorptiometry (DXA). There was a significant correlation between measured BF% and SPAS scores (r = 0.531, P < 0.001). Males scored lower on the SPAS compared to females (25.3 ± 9.4 vs. 33.1 ± 9.1, P < 0.001). The sample underestimated BF% with females underestimating by more than males, 5.7 ± 7.3% vs. 3.7 ± 5.4%, P = 0.036. There was no difference between perceived and measured weight for women (P = 0.500) however, males overestimated their weight (P = 0.004). There was a difference in appearance satisfaction pre and post body composition for females (pre = 4.4 ± 1.7, post = 4.2 ± 1.9, P = 0.026) but not for males (pre = 5.3 ± 1.5, post = 5.0 ± 1.8, P = 0.063). Overall, males had lower levels of SPA and higher levels of appearance satisfaction than females and knowledge of BF% negatively affected appearance satisfaction scores for females. Finally, both males and females underestimated BF% compared to DXA.

The influence of citrus aurantium and caffeine complex versus placebo on the cardiac autonomic response: a double blind crossover design.

BACKGROUND: The purpose of this study was to examine the resting cardiac autonomic nervous system's response to the ingestion of a complex containing Citrus aurantium + Caffeine (CA + C) and its influence on recovery following a high-intensity anaerobic exercise bout in habitual caffeine users. METHODS: Ten physically active males (25.1 ± 3.9 years; weight 78.71 ± 9.53 kg; height 177.2 ± 4.6 cm; body fat 15.5 ± 3.13%) participated in this study, which consisted of two exhaustive exercise protocols in a randomized crossover design. On each visit the participants consumed either a CA + C (100 mg of CA and 100 mg of C) or placebo (dextrose) capsule. After consumption, participants were monitored throughout a 45-min ingestion period, then completed a repeated Wingate protocol, and were then monitored throughout a 45-min recovery period. Cardiac autonomic function (Heart Rate (HR) and Heart Rate Variability (HRV)) and plasma epinephrine (E) and norepinephrine (NE) were taken at four different time points; Ingestion period: baseline (I1), post-ingestion period (I2); Recovery period: immediately post-exercise (R1), post-recovery period (R2). Heart rate variability was assessed in 5-min increments. RESULTS: A repeated measures ANOVA revealed significant time-dependent increases in HR, sympathetic related markers of HRV, and plasma E and NE at I2 only in the CA + C trial (p < 0.05); however, no meaningful changes in parasympathetic markers of HRV were observed. Participants recovered in a similar time-dependent manner in all markers of HRV and catecholamines following the PLA and CA + C trials. CONCLUSION: The consumption of CA + C results in an increase of sympathetic activity during resting conditions without influencing parasympathetic activity. CA + C provides no influence over cardiac autonomic recovery.

Central Hemodynamics Measured During 5 Repetition Maximum Free Weight Resistance Exercise.

The PhysioFlow™ is a piece of equipment that uses bioimpedance cardiography to measure central hemodynamics. The purpose of this research was to explore the novel approach of monitoring central hemodynamics during free weight resistance exercise using bioimpedance cardiography throughout a 5 repetition maximum (5RM). Thirty participants ranging from beginner to advanced lifters (16 males and 14 females) completed a 5RM for back squat, seated push press, and bicep curl while connected to the PhysioFlow™ to assess the response of heart rate (HR), stroke volume (SV), cardiac output (Q), and ejection fraction (EF). Participants were cued for form and to breathe normally throughout the lifts. The PhysioFlow™ detected an increase in HR and Q for all lifts between rest and each repetition (p < 0.05). There was also an increase in HR and Q from repetition 1 to repetition 5 for all lifts (p < 0.05). No changes in EF or SV were detected between resting measurements and each repetition for all lifts (p > 0.05) and no changes in EF or SV were detected when all repetitions were compared to each other for all lifts (p > 0.05). In conclusion, the PhysioFlow™ was able to detect changes in HR and Q during dynamic free weight resistance exercise. This novel approach may provide a mechanism for monitoring central hemodynamics during free weight resistance training. However, more research needs to be conducted as the exercise protocol for this investigation did not allow for a comparison to a reference method.

An investigation of the accuracy and reliability of body composition assessed with a handheld electrical impedance myography device.

The purpose of this study was to compare the body fat per cent (BF%) assessed with a unique handheld electrical impedance myography (EIM) device, along with other popular methods, to dual-energy X-ray absorptiometry (DXA). Participants included 33 males (aged 24.3 ± 4.6 years) and 38 females (aged 25.3 ± 8.9 years) who completed 2 visits separated by 24-72 h. The assessments included DXA, bioelectrical impedance analysis (BIA), skinfold measures (SKF), and three separate EIM measurements. No significant differences in BF% (P > 0.05) were found between all EIM assessments when compared against DXA for both males and females for each visit. All methods showed no significant differences in BF% (P > 0.05) between days within themselves. Across both days, the standard error of the estimate (SEE) for the EIM measurements ranged from 2.66% to 3.15%, the SEE for BIA was 2.80 and 2.85, and for SKF was 2.90 and 2.82. The 95% limits of agreement ranged from ±5.34% to ±6.38% for EIM measurements and were highest for SKF (±7.42% and ±7.47%). The total error for both days was largest for SKF (5.20% and 5.35%) and lowest for the EIM measurements (2.48-3.24%). This investigation supports use of a handheld EIM device as an accurate and reliable method of estimating BF% compared to DXA in young, apparently healthy individuals with BF% in the range of 10-22% for males and 20-32% in females and suggests this EIM device be considered a viable alternative to other established field measurements in this population.

Influence of acute consumption of caffeine vs. placebo over Bia-derived measurements of body composition: a randomized, double-blind, crossover design.

BACKGROUND: Bioelectrical impedance analysis (BIA) is often used to estimate total body water (TBW), intracellular body water (ICW), extracellular body water (ECW), and body fat percentage (BF%). A common restriction for BIA analysis is abstinence from caffeine 12-h prior to testing. However, research has yet to determine whether the consumption of caffeine influences BIA testing results. The purpose of this study was to determine if the consumption of caffeine influences BIA-derived BF% and body water values in habitual caffeine users. METHODS: Twenty apparently healthy males (26.6 ± 4.1 years) identified as habitual caffeine consumers (≥ one 95 mg serving per day ≥ four days per week) participated in this study. Participants came to the lab on three occasions, the first visit serving as the control (CON) with no supplementation. The remaining two visits were performed in a randomized double-blind, cross-over fashion. Participants consumed 200 mg of dextrose (PLA) or caffeine (CAF) in capsule form. During each visit, seven multi-frequency BIA measurements were conducted before (PRE) and after (15-min, 30-min, 45-min, 60-min, 75-min, 90-min) consumption. RESULTS: Repeated measures ANOVA revealed BF% for CAF was lower than the CON and PLA conditions at PRE and 15-min (p < 0.001, p = 0.004), but not statistically significant for the remaining time points (i.e., 30-, 45-, 60-, 75-, and 90-min). However, the effect size (ES) of the BF% differences were trivial. The CON, PLA, and CAF conditions had higher PRE ICW values than their associated post time points (i.e., 15-, 30-, 45-, 60-, 75-, and 90-min). Similar to BF%, ES of the mean differences for ICW were trivial. No other differences were observed. CONCLUSION: Caffeine consumption in habitual users produced trivial changes in TBW, ECW, ICW, or BF%. Therefore, the pre-testing guidelines for caffeine consumption may not be necessary in habitual caffeine consumers.